Poyales Francisco, Pérez Ricardo, López-Brea Israel, Zhou Ying, Rico Laura, Garzón Nuria
Miranza IOA, Madrid, Spain.
Optometry and Vision Department, Universidad Complutense, Madrid, Spain.
Clin Ophthalmol. 2020 Oct 13;14:3237-3247. doi: 10.2147/OPTH.S273641. eCollection 2020.
To compare clinical outcomes in a prospective trial of cataract surgery patients bilaterally implanted with two different trifocal intraocular lenses (IOLs) with very similar optical designs but consisting of different IOL materials (hydrophobic and hydrophilic).
Fifty-one patients (102 eyes) were randomized to receive trifocal IOLs bilaterally - FineVision POD F (hydrophilic) or FineVision POD F GF (hydrophobic) (both PhysIOL, Liége, Belgium). The follow-up period was 3 months. Outcome measurements included uncorrected distance (UDVA), corrected distance (CDVA), distance-corrected intermediate (DCIVA), and distance-corrected near visual acuity (DCNVA), refraction, negative dysphotopsia, optical quality of vision, contrast sensitivity under photopic and mesopic conditions, halometry (discrimination index), and patient-reported outcomes.
At the final study visit, mean (SD) values for binocular UDVA, CDVA, DCIVA (80 cm), and DCNVA (40 cm) were -0.01 (0.06), -0.04 (0.04), 0.09 (0.10), and 0.10 (0.09) logMAR, respectively, for POD F, and 0.01 (0.08), -0.03 (0.03), 0.08 (0.1), and 0.13 (0.11) respectively, for POD F GF. Defocus assessments showed a continuous curve with a functional range of visual acuity (≤0.15 logMAR) from ~30 cm to infinity in both groups. The discrimination index was >0.85 for all patients, and both groups showed similar contrast sensitivity under photopic and mesopic conditions. At 3 months, no patient reported negative dysphotopsia, and high satisfaction rates were observed.
Clinical outcomes showed no significant difference between each lens when measured at 1 month and 3 months after implantation. This equally good clinical performance of hydrophilic and hydrophobic trifocal lenses allows the surgeon to choose the IOL material based on personal preferences or patients' needs.
在一项前瞻性试验中,比较双侧植入两种不同三焦点人工晶状体(IOL)的白内障手术患者的临床结果。这两种IOL光学设计非常相似,但由不同的IOL材料(疏水和亲水)制成。
51例患者(102只眼)被随机分为双侧接受三焦点IOL——FineVision POD F(亲水)或FineVision POD F GF(疏水)(均为比利时列日的PhysIOL公司产品)。随访期为3个月。结果测量包括未矫正远视力(UDVA)、矫正远视力(CDVA)、距离矫正中间视力(DCIVA)和距离矫正近视力(DCNVA)、屈光、负性眩光、视觉光学质量、明视和暗视条件下的对比敏感度、光晕测量(辨别指数)以及患者报告的结果。
在最终研究访视时,POD F组双眼UDVA、CDVA、DCIVA(80 cm)和DCNVA(40 cm)的平均(标准差)值分别为-0.01(0.06)、-0.04(0.04)、0.09(0.10)和0.10(0.09)logMAR,POD F GF组分别为0.01(0.08)、-0.03(0.03)、0.08(0.1)和0.13(0.11)。散焦评估显示两组在约30 cm至无穷远范围内视力功能范围(≤0.15 logMAR)呈连续曲线。所有患者的辨别指数均>0.85,两组在明视和暗视条件下的对比敏感度相似。术后3个月,无患者报告负性眩光,且满意度较高。
植入后1个月和3个月测量时,各晶状体之间的临床结果无显著差异。亲水和疏水三焦点晶状体同样良好的临床表现使外科医生能够根据个人偏好或患者需求选择IOL材料。